LAVA Therapeutics N.V.

NASDAQ: LVTX · Real-Time Price · USD
1.52
-0.02 (-1.30%)
At close: Aug 15, 2025, 3:59 PM
1.52
-0.33%
After-hours: Aug 15, 2025, 04:04 PM EDT

LAVA Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
11.98M 6.77M 19.39M 5.35M
Cost of Revenue
467K 3.48M n/a n/a
Gross Profit
11.52M 3.29M 19.39M 5.35M
Operating Income
-29.69M -43.25M -34.84M -43.61M
Interest Income
3.76M 3.67M 339K n/a
Pretax Income
-24.48M -41.7M -31.66M -42.2M
Net Income
-25.11M -41.97M -31.91M -42.35M
Selling & General & Admin
13.22M 12.73M 14.12M 12.02M
Research & Development
28.45M 33.81M 40.1M 36.95M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
41.67M 46.54M 54.23M 46.92M
Interest Expense
515K 470K 82K 625K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
41.67M 50.02M 54.23M 46.92M
Income Tax Expense
630K 279K 249K 157K
Shares Outstanding (Basic)
26.83M 26.73M 25.92M 19.76M
Shares Outstanding (Diluted)
26.83M 26.73M 25.92M 19.76M
EPS (Basic)
-0.94 -1.57 -1.23 -2.14
EPS (Diluted)
-0.94 -1.57 -1.23 -2.14
EBITDA
-23.5M -40.53M -30.88M -41.02M
EBIT
-23.97M -41.14M -31.66M -41.57M
Depreciation & Amortization
467K 612K 781K 331K